Literature DB >> 26420908

Glutamine-dependent α-ketoglutarate production regulates the balance between T helper 1 cell and regulatory T cell generation.

Dorota Klysz1, Xuguang Tai2, Philippe A Robert3, Marco Craveiro1, Gaspard Cretenet1, Leal Oburoglu1, Cédric Mongellaz1, Stefan Floess4, Vanessa Fritz1, Maria I Matias1, Carmen Yong5, Natalie Surh1, Julien C Marie6, Jochen Huehn4, Valérie Zimmermann1, Sandrina Kinet1, Valérie Dardalhon7, Naomi Taylor7.   

Abstract

T cell activation requires that the cell meet increased energetic and biosynthetic demands. We showed that exogenous nutrient availability regulated the differentiation of naïve CD4(+) T cells into distinct subsets. Activation of naïve CD4(+) T cells under conditions of glutamine deprivation resulted in their differentiation into Foxp3(+) (forkhead box P3-positive) regulatory T (Treg) cells, which had suppressor function in vivo. Moreover, glutamine-deprived CD4(+) T cells that were activated in the presence of cytokines that normally induce the generation of T helper 1 (TH1) cells instead differentiated into Foxp3(+) Treg cells. We found that α-ketoglutarate (αKG), the glutamine-derived metabolite that enters into the mitochondrial citric acid cycle, acted as a metabolic regulator of CD4(+) T cell differentiation. Activation of glutamine-deprived naïve CD4(+) T cells in the presence of a cell-permeable αKG analog increased the expression of the gene encoding the TH1 cell-associated transcription factor Tbet and resulted in their differentiation into TH1 cells, concomitant with stimulation of mammalian target of rapamycin complex 1 (mTORC1) signaling. Together, these data suggest that a decrease in the intracellular amount of αKG, caused by the limited availability of extracellular glutamine, shifts the balance between the generation of TH1 and Treg cells toward that of a Treg phenotype.
Copyright © 2015, American Association for the Advancement of Science.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26420908     DOI: 10.1126/scisignal.aab2610

Source DB:  PubMed          Journal:  Sci Signal        ISSN: 1945-0877            Impact factor:   8.192


  161 in total

1.  T cells: Nutrients guide differentiation.

Authors:  Elisabeth Kugelberg
Journal:  Nat Rev Immunol       Date:  2015-10-16       Impact factor: 53.106

Review 2.  Harnessing the plasticity of CD4(+) T cells to treat immune-mediated disease.

Authors:  Michel DuPage; Jeffrey A Bluestone
Journal:  Nat Rev Immunol       Date:  2016-02-15       Impact factor: 53.106

Review 3.  Targeting Metabolism to Improve the Tumor Microenvironment for Cancer Immunotherapy.

Authors:  Jackie E Bader; Kelsey Voss; Jeffrey C Rathmell
Journal:  Mol Cell       Date:  2020-06-18       Impact factor: 17.970

4.  Distinct Regulation of Th17 and Th1 Cell Differentiation by Glutaminase-Dependent Metabolism.

Authors:  Marc O Johnson; Melissa M Wolf; Matthew Z Madden; Gabriela Andrejeva; Ayaka Sugiura; Diana C Contreras; Damian Maseda; Maria V Liberti; Katelyn Paz; Rigel J Kishton; Matthew E Johnson; Aguirre A de Cubas; Pingsheng Wu; Gongbo Li; Yongliang Zhang; Dawn C Newcomb; Andrew D Wells; Nicholas P Restifo; W Kimryn Rathmell; Jason W Locasale; Marco L Davila; Bruce R Blazar; Jeffrey C Rathmell
Journal:  Cell       Date:  2018-11-01       Impact factor: 41.582

Review 5.  Role of Metabolism in the Immunobiology of Regulatory T Cells.

Authors:  Mario Galgani; Veronica De Rosa; Antonio La Cava; Giuseppe Matarese
Journal:  J Immunol       Date:  2016-10-01       Impact factor: 5.422

Review 6.  Microenvironmental Metabolism Regulates Antitumor Immunity.

Authors:  Verra M Ngwa; Deanna N Edwards; Mary Philip; Jin Chen
Journal:  Cancer Res       Date:  2019-07-30       Impact factor: 12.701

Review 7.  Cancer Metabolism Drives a Stromal Regenerative Response.

Authors:  Simon Schwörer; Santosha A Vardhana; Craig B Thompson
Journal:  Cell Metab       Date:  2019-02-14       Impact factor: 27.287

8.  CD4 T cells differentially express cellular machinery for serotonin signaling, synthesis, and metabolism.

Authors:  Hera Wu; DeVon Herr; Nancie J MacIver; Jeffrey C Rathmell; Valerie A Gerriets
Journal:  Int Immunopharmacol       Date:  2020-08-28       Impact factor: 4.932

9.  mTOR Inhibitor Everolimus in Regulatory T Cell Expansion for Clinical Application in Transplantation.

Authors:  Roberto Gedaly; Felice De Stefano; Lilia Turcios; Marita Hill; Giovanna Hidalgo; Mihail I Mitov; Michael C Alstott; D Allan Butterfield; Hunter C Mitchell; Jeremy Hart; Ahmad Al-Attar; Chester D Jennings; Francesc Marti
Journal:  Transplantation       Date:  2019-04       Impact factor: 4.939

Review 10.  Immunometabolism of regulatory T cells.

Authors:  Ryan Newton; Bhavana Priyadharshini; Laurence A Turka
Journal:  Nat Immunol       Date:  2016-05-19       Impact factor: 25.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.